Related Experiment Video
Updated: Aug 6, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Radioiodine refractory thyroid cancer; Bridging multidisciplinary synergy
Georgios Christantoniou1, Maria Boudina
1Unit of Endocrinology-Endocrine Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece. christantoniougeorge@gmail.com.
Hellenic Journal of Nuclear Medicine
|July 19, 2026
Summary
Differentiated thyroid cancer (DTC) often has a good prognosis but can become resistant to radioiodine therapy (RAIR-DTC). This review covers challenges in diagnosing and treating this complex condition.
Area of Science:
- Oncology
- Endocrinology
Background:
- Differentiated thyroid carcinoma (DTC) is the most common thyroid cancer.
- While typically having a favorable prognosis, a subset of patients develop radioiodine (RAI) refractoriness (RAIR-DTC).
Purpose of the Study:
- To explore diagnostic challenges in RAIR-DTC.
- To evaluate prognostic factors for RAIR-DTC.
- To review the evolving therapeutic landscape for RAIR-DTC.
Main Methods:
- Literature review of diagnostic modalities.
- Analysis of prognostic indicators.
- Synthesis of current and emerging treatment strategies.
Main Results:
- RAIR-DTC presents significant diagnostic hurdles.
- Prognostic evaluation is crucial for guiding management.
- Integrated oncology care is essential for optimal patient outcomes.
Conclusions:
- RAIR-DTC requires a multidisciplinary approach.
- Advances in understanding and treatment are improving patient care.
- Continued research is vital for further progress in managing RAIR-DTC.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...